Vyome Holdings (HIND) Times Interest Earned (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Times Interest Earned of -$7.82 for Q1 2026, down 359.62% year-over-year from $3.01 in Q1 2025, and up 82.83% quarter-over-quarter from -$45.56 in Q4 2025.
Vyome Holdings (HIND) Times Interest Earned (2015 - 2026) Analysis & Trends
Vyome Holdings' Times Interest Earned history runs 12 years deep, the most recent figure standing at -$7.82 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 359.62% year-over-year to -$7.82; the TTM figure through Mar 2026 stood at -$43.65 (down 663.81% YoY), while the FY2025 annual figure was -$0.14, down 9.26% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$7.82, up from -$45.56 in the prior quarter.
- The five-year high for Times Interest Earned was -$1.05 in Q3 2024, with the low at -$334.88 in Q3 2025.
- The 5-year median for Times Interest Earned is -$35.09 (2023), against an average of -$55.86.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned jumped 98.4% in 2024, then plunged 31697.66% in 2025.
- Vyome Holdings' Times Interest Earned stood at -$191.87 in 2022, then jumped by 81.71% to -$35.09 in 2023, then surged by 85.57% to -$5.06 in 2024, then plunged by 799.68% to -$45.56 in 2025, then jumped by 82.83% to -$7.82 in 2026.
- Business Quant data shows HIND's Times Interest Earned at -$7.82 in Q1 2026, -$45.56 in Q4 2025, and -$334.88 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | -259.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.04 |
| Mar 31, 2026 | -7.82 |
| Dec 31, 2025 | -45.56 |
| Sep 30, 2025 | -334.88 |
| Jun 30, 2025 | -23.41 |
| Mar 31, 2025 | -1.70 |
| Dec 31, 2024 | -5.06 |
| Sep 30, 2024 | -1.05 |
| Jun 30, 2024 | -8.89 |
| Mar 31, 2024 | -37.46 |
| Dec 31, 2023 | -35.09 |
| Sep 30, 2023 | -65.76 |
| Jun 30, 2023 | -11.73 |
| Mar 31, 2023 | -64.72 |
| Dec 31, 2022 | -191.87 |
| Sep 30, 2022 | -47.31 |
| Jun 30, 2022 | -26.64 |
| Mar 31, 2022 | -40.57 |
| Dec 31, 2021 | -187.58 |
| Sep 30, 2021 | -29.91 |